Extract notice to the Minister

Qosequ (ostéoporose)

Common name / Subject : dénosumab
Name of the manufacturer : Mantra Ph.
Form : Sol. Inj. S.C. (ser.)
Dosage : 60 mg/ml (1 ml)

Indication : Ostéoporose

INESSS' Recommendation
Inscription – Sous conditions 

Minister's decisions
À venir

Evaluation published on October 14, 2026

INESSSid: 25734
Recevable on January 13, 2025

Download Advice to minister about Qosequ (ostéoporose)

Extrait d'avis à la ministre sur Qosequ 328 KiO

Subscribe to our newsletter now

Subscription